KeyBanc Starts Innospec (IOSP) at Buy
Get Alerts IOSP Hot Sheet
Price: $122.04 --0%
Rating Summary:
4 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 11 | New: 6
Rating Summary:
4 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 11 | New: 6
Join SI Premium – FREE
KeyBanc initiates coverage on Innospec (NASDAQ: IOSP) with a Buy. PT $40.00.
"Its leading market position in its core Fuel Additives business offers a stable earnings stream and returns, while a solid position as a producer of surfactants for the personal care market adds to its attractive returns," the firm comments. "On top of this, we believe that IOSP possesses an opportunity to grow its oilfield chemicals business while also expanding its personal care business both organically and through bolt-on acquisitions."
For an analyst ratings summary and ratings history on Innospec click here. For more ratings news on Innospec click here.
Shares of Innospec closed at $29.57 yesterday.
"Its leading market position in its core Fuel Additives business offers a stable earnings stream and returns, while a solid position as a producer of surfactants for the personal care market adds to its attractive returns," the firm comments. "On top of this, we believe that IOSP possesses an opportunity to grow its oilfield chemicals business while also expanding its personal care business both organically and through bolt-on acquisitions."
For an analyst ratings summary and ratings history on Innospec click here. For more ratings news on Innospec click here.
Shares of Innospec closed at $29.57 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bristol-Myers Squibb (BMY) stock slips despite earnings beat
- Northfield Bancorp (NFBK) Reports In-Line Q1 EPS
- American Airlines (AAL) Misses Q1 EPS by 7c, Guidance Beats
Create E-mail Alert Related Categories
New CoverageRelated Entities
KeyBanc, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!